Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03846687 · ClinicalTrials.gov registry record
Validation of Patient Reported Outcome Measures for Use in Hallux Valgus
A clinical trial of Hallux Valgus, sponsored by Ipsen.
- Completed
- Registry status
- 21
- Enrollment target
- 3
- Study locations
NCT03846687 is a study of Hallux Valgus that has completed, run by Ipsen. The registered enrollment target is 21 participants, below the 79-participant average among 4 other Hallux Valgus trials with a reported enrollment target (73% lower). The trial reports 3 study locations across 3 states.
The verdict
NCT03846687, a study of Hallux Valgus, has completed, sponsored by Ipsen.
- COMPLETED
- Registry status
- 21 participants
- Enrollment target
- 3
- Study locations
Study Summary
The purpose of the study is to explore whether the mFFI is fit for purpose in adults with hallux valgus (HV).
Conditions Studied
Study Locations (3)
California
- University Foot and Ankle Institute - Santa Monica
Ohio
- Ankle and Foot Care Centers - Youngstown
Texas
- Futuro Clinical Trials, LLC - McAllen
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 21 participants |
| Start Date | 2018-10-30 |
| Est. Completion | 2020-01-15 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03846687
The ClinicalTrials.gov registry entry for NCT03846687 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 21 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 79-participant average among 4 other Hallux Valgus trials with a reported enrollment target (73% lower). The listed sponsor is Ipsen, which has 85 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Hallux Valgus appearing as the primary indexed condition, and to 0 interventions.
NCT03846687 reports 3 study locations spanning 3 distinct geographic areas - top geographies include California, Ohio, Texas.
Frequently Asked Questions
What is clinical trial NCT03846687 about?
NCT03846687 is a clinical study titled "Validation of Patient Reported Outcome Measures for Use in Hallux Valgus". The purpose of the study is to explore whether the mFFI is fit for purpose in adults with hallux valgus (HV).
What is the current status of trial NCT03846687?
This trial is currently completed. The enrollment target is 21 participants. The study started on 2018-10-30. Estimated completion is 2020-01-15.
What conditions does trial NCT03846687 study?
This clinical trial studies the following conditions: Hallux Valgus.
Who is sponsoring clinical trial NCT03846687?
This trial is sponsored by Ipsen, which has 85 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT03846687 being conducted?
This trial has 3 study locations across California, Ohio, Texas. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Hallux Valgus
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Outcomes Following Combined Adductoplasty™ and Lapiplasty® (MTA3D)
RECRUITING · NA
-
Early Weight-Bearing After the Lapiplasty Procedure
ACTIVE NOT RECRUITING · NA
-
Feasibility of an Analgesic Device Enabling Local Anesthetic Delivery and Neuromodulation After Shoulder/Foot Surgery
COMPLETED · NA
-
Patient Reported Function Following Combined First MTP and First TMT Arthrodesis.
COMPLETED · NA
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.